Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Tasocitinib shows promising pharmacokinetics in ocular tissues

Dec. 15, 2010

ATL-313 and dexamethasone have synergistic antitumor effect in models of multiple myeloma

Dec. 15, 2010

EyeGene's EGT-022 shows therapeutic potential in retinopathy model

Dec. 14, 2010

Nerviano discloses promising preclinical/clinical data on new oncolytic compounds

Dec. 14, 2010

Kinase inhibitors from Bayer show oncolytic activity alone and in combination

Dec. 14, 2010

Phase I and preclinical data presented on PD-0332991 in multiple myeloma

Dec. 14, 2010

Oncolytic agent S-110 shows promising preclinical results and advances into clinic

Dec. 13, 2010

Adding ganitumab to exemestane or fulvestrant does not improve PFS in patients with breast cancer

Dec. 13, 2010

CHR-2845 is well tolerated in first-in-human study

Dec. 13, 2010

Safety and preliminary antitumor activity of CEP-18770 reported in first-in-human study

Dec. 13, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...